661 Dipeptidyl peptidase-9 (DPP9) overexpression is a potential response-predictive biomarker of BXCL701 and pembrolizumab combination treatment in mCRPC patients with SCNC phenotype
oleh: Vincent O’Neill, Veena Agarwal, Moses K Donkor, Sherry Kupchick, Rashmi Deshpande, Dawn Newmin
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2023-11-01 |
Deskripsi
No description available for this item.